Spark Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Spark Investment Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-91,400	Closed	-$95K	–	824
2019 Q1	$95K	Hold	91,400	–	–	﹤0.01%	577
2018 Q4	$68K	Sell	91,400 -4,300	-4%	-$6.47K	﹤0.01%	587
2018 Q3	$202K	Sell	95,700 -38,700	-29%	-$92.7K	0.01%	566
2018 Q2	$310K	Buy	134,400 +19,500	+17%	+$56.8K	0.02%	497
2018 Q1	$365K	Buy	114,900 +59,100	+106%	+$163K	0.02%	439
2017 Q4	$228K	Buy	+55,800	New	+$243K	0.01%	552
2015 Q2	–	Sell	-17,000	Closed	-$437K	–	843
2015 Q1	$437K	Sell	17,000 -600	-3%	-$15.2K	0.06%	399
2014 Q4	$382K	Buy	+17,600	New	+$361K	0.06%	368

Spark Investment Management's OMED Position: Q2 2019 in Review

Spark Investment Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 91,400 shares — an estimated $95K sold.

Spark Investment Management first reported a position in OMED in Q4 2014 and held it in 8 quarters. The position peaked at $437K in Q1 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Spark Investment Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Spark Investment Management sold 91,400 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $95K.
Spark Investment Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 8 quarters.
Spark Investment Management's OncoMed Pharmaceuticals, Inc. position peaked at $437K in Q1 2015.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.